Mahdi Habibi‐Anbouhi

Author

Also Known As

Anbouhi, Mahdi Habibi, Habibi Anbouhi, Mahdi, M Habibi-Anbouhi, M. Habibi-Anbouhi, Mahdi Habibi Anbouhi, Mahdi Habibi-Anbouhi, Mahdi Habibi‐Anbouhi, MahdiHabibi Anbouhi

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Pasteur Institute of Iran Biotechnology Research Center Vrije Universiteit Brussel Tehran University of Medical Sciences Academic Center for Education, Culture and Research

About

Mahdi Habibi‐Anbouhi is an author at Pasteur Institute of Iran specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	635
2	Engineering	9	9	377
3	Natural Sciences	4	4	88
4	Biochemistry	3	3	78
5	Allergy	1	1	21

Mahdi Habibi‐Anbouhi

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor Mahdi Behdani, Sirous Zeinali, Hossein Khanahmad, Molecular Immunology Functional NanobodyVascular Tissue EngineeringNanotherapeuticsAngiogenesisAngiogenesis Cell Receptor	2011	111
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth Mahdi Behdani, Sirous Zeinali, Morteza Karimipour, New Biotechnology NanomedicineTumor Cell GrowthEngineeringNanobiotechnologyVegfr2-specific Nanobody Pseudomonas	2012	77
Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody Fatemeh Kazemi‐Lomedasht, Mahdi Behdani, Kamran Pooshang Bagheri, Molecular Immunology Tissue EngineeringHuman Endothelial CellAngiogenesisEngineeringVascular Biology	2015	67
Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes Ensiyeh Hajizadeh‐Saffar, Yaser Tahamtani, Nasser Aghdami, Scientific Reports	2015	48
An overview on application of phage display technique in immunological studies Abbas Rami, Mahdi Behdani, Najmeh Yardehnavi, Asian Pacific Journal of Tropical Biomedicine Immunocytochemical TechniqueImmunologyImmunotherapyPhage DisplayBioanalysis	2017	42
Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization Amir Sadeghi, Mahdi Behdani, Serge Muyldermans, Drug Testing and Analysis	2019	40
A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line Meghdad Abdollahpour‐Alitappeh, Seyed Masoud Hashemi Karouei, Majid Lotfinia, Artificial Cells Nanomedicine and Biotechnology Rituximab ActivityMedicinal ChemistryMedicineParental RituximabImmunology	2018	36
Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets Zhila Izadi, Ensiyeh Hajizadeh‐Saffar, Jamshid Hadjati, Biomaterials Pancreatic IsletsPancreatic CancerSurface ImmobilizationImmunologyAutoimmunity	2018	36
A camelid antibody candidate for development of a therapeutic agent against <i>Hemiscorpius lepturus</i> envenomation Najmeh Yardehnavi, Mahdi Behdani, Kamran Pooshang Bagheri, The FASEB Journal	2014	30
An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization Rasoul Baharlou, Nader Tajik, Mahdi Behdani, Immunopharmacology and Immunotoxicology	2018	30

Page 1